Litigation Details for Pharmacyclics LLC v. Zydus Worldwide DMCC (D. Del. 2019)
✉ Email this page to a colleague
Pharmacyclics LLC v. Zydus Worldwide DMCC (D. Del. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-01-28 |
| Court | District Court, D. Delaware | Date Terminated | 2021-05-11 |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | None | Referred To | |
| Patents | 10,106,548; 10,125,140; 7,514,444; 8,008,309; 8,476,284; 8,497,277; 8,697,711; 8,735,403; 8,754,090; 8,754,091; 8,952,015; 8,957,079; 9,181,257; 9,296,753; 9,725,455 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Pharmacyclics LLC v. Zydus Worldwide DMCC
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Pharmacyclics LLC v. Zydus Worldwide DMCC (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2019-01-24 | 1 | to the expiration of the U.S. Patent Nos. 7,514,444 (“the ’444 Patent”); Case 1:19-cv-00143-CFC Document…8,008,309 (“the ’309 Patent”); 8,697,711 (“the ’711 Patent”); 8,735,403 (“the ’403 Patent”); 8,957,079 (“…(“the ’079 Patent”); 9,181,257 (“the ’257 Patent”); 8,754,091 (“the ’091 Patent”); 8,497,277 (“the ’277…’277 Patent”); 8,952,015 (“the ’015 Patent”); 8,476,284 (“the ’284 Patent”); 8,754,090 (“the ’090 Patent…,753 (“the ’753 Patent”); 9,725,455 (“the ’455 Patent”); 10,125,140 (“the ’140 Patent”); and 10,106,548 | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
